chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Anxiety, Computerised tomogram, Syncope
Clinical narrative: HPV #1 & Hep A administered on 3/9/10. Pt waited 30 minutes in clinic with no problems. Pt. came in 5/10/10 and informed me that on 3/9/10 she became anxious and fainted. Her mother called 9-1-1 and she was taken to the ER. ER visit WNL and patient was put on XANAX PRN by MD. Pt stated she became anxious that night when she started thinking about and reading the possible side effects of the HPV vaccine.
Age: 52.0
Sex: F
Vaccine: HEP
Symptoms: Paralysis, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 52-year-old female subject who was vaccinated with HEPATITIS B vaccine (manufacturer unspecified). On an unspecified date the subject received 3rd dose of HEPATITIS B vaccine (unknown). Five days after vaccination with HEPATITIS B vaccine, the subject experienced uveitis and paralysis. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after HEPATITIS B vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of HEPATITIS B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Patient's mother stated right arm was 1.5 times bigger than left arm. Arm was also warm to touch and had low-grade fever. Mother applied cool compresses to right arm.
Age: 61.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: (R) deltoid tenderness since injection, now a raised, erythematous patch 1cm x 2 cm.
Age: 29.0
Sex: M
Vaccine: HEP
Symptoms: Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 29-year-old male subject who was vaccinated with Hepatitis B (manufacturer unspecified). On an unspecified date the subject received 1st dose of Hepatitis B (unknown). Two days after vaccination with Hepatitis B, the subject experienced uveitis. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis B vaccine between 1982 and 2009. It appeared that all subjects recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 29.0
Sex: F
Vaccine: HEP, TYP
Symptoms: Arthralgia, Erythema nodosum, Pyrexia, Red blood cell sedimentation rate increased, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 29-year-old female subject who was vaccinated with hepatitis B vaccine recombinant (Hepatitis B vaccine, manufacturer unspecified). Concurrent vaccination included Salmonella typhi Vi capsular polysaccharide vaccine ;manufacturer unspecified given on an unspecified date. On an unspecified date the subject received 1st dose of Hepatitis B vaccine (unknown). One day after vaccination with Hepatitis B vaccine, the subject experienced uveitis, arthralgia, erythema nodosum and fever. This case was assessed as medically serious by GSK. Relevant test results included elevated sedimentation rate. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 20.0
Sex: F
Vaccine: HEP
Symptoms: Headache, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 20-year-old female subject who was vaccinated with Hepatitis B (manufacturer unspecified). On an unspecified date the subject received 2nd dose and 3rd dose of Hepatitis B (unknown). Three days after vaccination with 2nd dose of Hepatitis B and 4 days after vaccination with 3rd dose of Hepatitis B, the subject experienced uveitis and headache. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 6.0
Sex: M
Vaccine: FLUN(H1N1)
Symptoms: Incorrect dose administered
Clinical narrative: Only half of vaccine dosage was administered.
Age: 6.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Incorrect dose administered
Clinical narrative: Nurse only administered half of vaccine dosage.
Age: 6.0
Sex: M
Vaccine: FLUN(H1N1)
Symptoms: Incorrect dose administered
Clinical narrative: Nurse only administered half of vaccine dosage.
Age: 39.0
Sex: F
Vaccine: HEP
Symptoms: Chest discomfort, Ocular hyperaemia
Clinical narrative: Chest heaviness, eyes became red.
Age: 7.0
Sex: M
Vaccine: FLUN(H1N1)
Symptoms: Incorrect dose administered
Clinical narrative: Nurse only administered half of vaccine dosage.
Age: 0.36
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Incorrect dose administered
Clinical narrative: Nurse only administered half of vaccine dosage.
Age: 45.0
Sex: F
Vaccine: HEPA
Symptoms: Blister, Rash erythematous
Clinical narrative: Rash with raised blisters in middle and red around edges located on stomach, under breast, few on back, chest, legs had about 20 per quadrant.
Age: 9.0
Sex: M
Vaccine: FLUN(H1N1)
Symptoms: Incorrect dose administered
Clinical narrative: Nurse only administered half of vaccine dosage.
Age: 9.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Incorrect dose administered
Clinical narrative: Nurse only administered half of vaccine dosage.
Age: 8.0
Sex: M
Vaccine: FLUN(H1N1)
Symptoms: Incorrect dose administered
Clinical narrative: Nurse only administered half of vaccine dosage.
Age: 7.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Incorrect dose administered
Clinical narrative: Nurse only administered half of the vaccine dosage.
Age: 37.0
Sex: F
Vaccine: HEP
Symptoms: Influenza like illness, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 37-year-old female subject who was vaccinated with Hepatitis B (manufacturer unspecified). On an unspecified date the subject received 1st dose of Hepatitis B (unknown). Seven days after vaccination with Hepatitis B, the subject experienced uveitis and flu like symptoms. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 39.0
Sex: M
Vaccine: HEP
Symptoms: Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 39-year-old male subject who was vaccinated with hepatitis B vaccine recombinant (Hepatitis B vaccine, manufacturer unspecified). On an unspecified date the subject received 3rd dose of Hepatitis B vaccine (unknown). One day after vaccination with Hepatitis B vaccine, the subject experienced uveitis. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 16.0
Sex: F
Vaccine: HEP
Symptoms: Conjunctivitis, Keratitis, Scleritis, Skin nodule, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 16-year-old female subject who was vaccinated with hepatitis B vaccine recombinant (Hepatitis B vaccine, manufacturer unspecified). On an unspecified date the subject received unspecified dose of Hepatitis B vaccine (unknown). At an unspecified time after vaccination with Hepatitis B vaccine, the subject experienced uveitis, keratitis, conjunctivitis, scleritis and skin nodule. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Arthralgia, Erythema nodosum, Pyrexia, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 28-year-old female subject who was vaccinated with Hepatitis B (manufacturer unspecified). Previous and/or concurrent vaccination included Salmonella typhi Vi capsular polysaccharide vaccine; manufacturer unspecified; unknown given on an unspecified date. On an unspecified date the subject received 1st dose of Hepatitis B (unknown). Seven days after vaccination with Hepatitis B, the subject experienced uveitis, arthralgia, erythema, nodosum and fever. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 47.0
Sex: F
Vaccine: HEP
Symptoms: Retinopathy, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 47-year-old female subject who was vaccinated with hepatitis B vaccine recombinant (Hepatitis B vaccine, manufacturer unspecified). On an unspecified date the subject received unspecified dose of Hepatitis B vaccine (unknown). At an unspecified time after vaccination with Hepatitis B vaccine, the subject experienced uveitis and retinopathy. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all the subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 58.0
Sex: M
Vaccine: HEP
Symptoms: Retinopathy, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 58-year-old male subject who was vaccinated with hepatitis B vaccine recombinant (Hepatitis B vaccine, manufacturer unspecified). On an unspecified date the subject received 3rd dose of Hepatitis B vaccine (unknown). One day after vaccination with Hepatitis B vaccine, the subject experienced uveitis and retinopathy. This case was assessed as medically serious by GSK. This is one of the 32 cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes which initiated the ocular response of uveitis.
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Headache, Influenza like illness, Lymphadenopathy, Meningitis, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 28-year-old female subject who was vaccinated with Hepatitis B (manufacturer unspecified). Concurrent medications included Prednisolone and Diclofenac. On an unspecified date the subject received 1st dose of Hepatitis B (unknown). Fifteen days  after vaccination with Hepatitis B, the subject experienced uveitis, meningitis, lymphadenopathy, influenza like symptoms and headache. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 35.0
Sex: F
Vaccine: HEP
Symptoms: Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 35-year-old female subject who was vaccinated with Hepatitis B vaccine (manufacturer unspecified). On an unspecified date the subject received 1st dose of Hepatitis B vaccine (unknown). One day after vaccination with Hepatitis B vaccine, the subject experienced uveitis. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 17.0
Sex: F
Vaccine: HEP
Symptoms: Autoimmune disorder, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 17-year-old female subject who was vaccinated with hepatitis B vaccine recombinant (Hepatitis B vaccine, manufacturer unspecified). On an unspecified date the subject received 2nd dose of hepatitis B vaccine (unknown). One day after vaccination with Hepatitis B vaccine, the subject experienced uveitis and autoimmune disorder. This case was assessed as medically serious by GSK. This case is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 6.0
Sex: M
Vaccine: FLUN(H1N1)
Symptoms: Incorrect dose administered
Clinical narrative: Nurse only administered half of the vaccine dosage.
Age: 24.0
Sex: F
Vaccine: ANTH
Symptoms: Blood folate, Blood human chorionic gonadotropin, Blood thyroid stimulating hormone, Full blood count, Hypoaesthesia
Clinical narrative: Pt c/o numbness and tingling X 4 days on the L side of her body. Pt states it sometimes is one part like her leg and other times it is several parts of her L body at the same time. Pt describes the tingling like 'when you sleep on your arm and it goes to sleep; and when you start to move it, it starts to have the needle feeling.' Pt states unable to perform simple finger exercises at times during these episodes.
Age: 24.0
Sex: F
Vaccine: ANTH
Symptoms: Metabolic function test, Nuclear magnetic resonance imaging brain normal, Paraesthesia, Pregnancy test
Clinical narrative: Pt c/o numbness and tingling X 4 days on the L side of her body. Pt states it sometimes is one part like her leg and other times it is several parts of her L body at the same time. Pt describes the tingling like 'when you sleep on your arm and it goes to sleep; and when you start to move it, it starts to have the needle feeling.' Pt states unable to perform simple finger exercises at times during these episodes.
Age: 11.0
Sex: M
Vaccine: HPV4, IPV, MNQ, TDAP, VARCEL
Symptoms: Activities of daily living impaired, Blood test, Crying, Headache, Pain in extremity
Clinical narrative: Mother called in am of day following vaccinations (6/23) to report that child had "slight fever, headache, sore arm." RN advised her to give him ibuprofen and monitor if condition worsened. Mother called back later in day to report that he no longer had a fever or sore arm, but that he "had a severe headache" and was "not able to get up and was continually crying." Mother was then advised to take him to Urgent Care/ER. Telephone follow-up was done with mother the next day (6/24), and she reported that she did take him to ER, and they checked him out. Says she was told it was "probably a vaccine reaction since he got several shots." Says that he had no more problems, and had completely recovered.
Age: 11.0
Sex: M
Vaccine: HPV4, IPV, MNQ, TDAP, VARCEL
Symptoms: Pyrexia, Vaccination complication
Clinical narrative: Mother called in am of day following vaccinations (6/23) to report that child had "slight fever, headache, sore arm." RN advised her to give him ibuprofen and monitor if condition worsened. Mother called back later in day to report that he no longer had a fever or sore arm, but that he "had a severe headache" and was "not able to get up and was continually crying." Mother was then advised to take him to Urgent Care/ER. Telephone follow-up was done with mother the next day (6/24), and she reported that she did take him to ER, and they checked him out. Says she was told it was "probably a vaccine reaction since he got several shots." Says that he had no more problems, and had completely recovered.
Age: 26.0
Sex: M
Vaccine: FLU(H1N1), FLU3, TDAP
Symptoms: Blister, Erythema, Heat rash, Insomnia, Myalgia
Clinical narrative: After approximately 1 hr after administration (IM) of TDAP and other injections I broke out in a "heat rash" like lesions over my elbows, knees, digital interspaces of feet and hands, groin, and underarms, as well as palms of hand, preceded by blisters (?) contact with rough clothing and car interior, (with exception of feet and hands). 7/1/2010 Follow up: 26 year old physician reported receipt of influenza (IM-Fluzone-Sanofi-Pasteur), H1N1 (IM-Sanofi-Pasteur) and BOOSTRIX (GSK) vaccines on 15 June 2010 with transfer to new command. Approximately 1-2 hours later he noted a prickly itching sensation with onset of "heat rash" to bilateral palms of hands and posterior elbows. The reddened areas to elbows were warm to touch. He had been touching black leather steering wheel cover and seat arm rest in his car (not new). Heat index at time in area was >100 degree's. There were scattered red mascules to posterior arm (upper/lower). This pruritic non-scaly red macular rash (heat rash) progressed over next 12-24 hours to include bilateral feet, groin, and posterior knees. He described any facial or chest lesions, oral lesions, or systemic symptoms such as headaches, fevers, nausea, vomiting, diarrhea, joint pain, or respiratory distress. he denied any target lesions. He did admit to mild myalgia which resolved within 24-48 hours. He did wear a new uniforma from new cleaners but advised no skin reactions with other uniforms cleaned at the same facility at same time. He denied any new detergents, deordorants, food groups, colognes, etc. He denied any recent illness but does work at a hospital. He self treated this "rash" with topical BENADRYL and colloidal oatmeal bath with relief of symptoms after 3 days. He admitted to difficulty sleeping x 3 days due to itchy feet. On day 13 96/28/2010) he was referred to Vaccine Healthcare Center by Immunization department of VAERS submission and concerns about possible diagnossi of Erythema Multiforme. Symptoms: Rash, oth nonspecific skin eruption(782.1).
Age: 26.0
Sex: M
Vaccine: FLU(H1N1), FLU3, TDAP
Symptoms: Paraesthesia, Pruritus, Rash, Rash macular, Rash pruritic
Clinical narrative: After approximately 1 hr after administration (IM) of TDAP and other injections I broke out in a "heat rash" like lesions over my elbows, knees, digital interspaces of feet and hands, groin, and underarms, as well as palms of hand, preceded by blisters (?) contact with rough clothing and car interior, (with exception of feet and hands). 7/1/2010 Follow up: 26 year old physician reported receipt of influenza (IM-Fluzone-Sanofi-Pasteur), H1N1 (IM-Sanofi-Pasteur) and BOOSTRIX (GSK) vaccines on 15 June 2010 with transfer to new command. Approximately 1-2 hours later he noted a prickly itching sensation with onset of "heat rash" to bilateral palms of hands and posterior elbows. The reddened areas to elbows were warm to touch. He had been touching black leather steering wheel cover and seat arm rest in his car (not new). Heat index at time in area was >100 degree's. There were scattered red mascules to posterior arm (upper/lower). This pruritic non-scaly red macular rash (heat rash) progressed over next 12-24 hours to include bilateral feet, groin, and posterior knees. He described any facial or chest lesions, oral lesions, or systemic symptoms such as headaches, fevers, nausea, vomiting, diarrhea, joint pain, or respiratory distress. he denied any target lesions. He did admit to mild myalgia which resolved within 24-48 hours. He did wear a new uniforma from new cleaners but advised no skin reactions with other uniforms cleaned at the same facility at same time. He denied any new detergents, deordorants, food groups, colognes, etc. He denied any recent illness but does work at a hospital. He self treated this "rash" with topical BENADRYL and colloidal oatmeal bath with relief of symptoms after 3 days. He admitted to difficulty sleeping x 3 days due to itchy feet. On day 13 96/28/2010) he was referred to Vaccine Healthcare Center by Immunization department of VAERS submission and concerns about possible diagnossi of Erythema Multiforme. Symptoms: Rash, oth nonspecific skin eruption(782.1).
Age: 26.0
Sex: M
Vaccine: FLU(H1N1), FLU3, TDAP
Symptoms: Skin warm
Clinical narrative: After approximately 1 hr after administration (IM) of TDAP and other injections I broke out in a "heat rash" like lesions over my elbows, knees, digital interspaces of feet and hands, groin, and underarms, as well as palms of hand, preceded by blisters (?) contact with rough clothing and car interior, (with exception of feet and hands). 7/1/2010 Follow up: 26 year old physician reported receipt of influenza (IM-Fluzone-Sanofi-Pasteur), H1N1 (IM-Sanofi-Pasteur) and BOOSTRIX (GSK) vaccines on 15 June 2010 with transfer to new command. Approximately 1-2 hours later he noted a prickly itching sensation with onset of "heat rash" to bilateral palms of hands and posterior elbows. The reddened areas to elbows were warm to touch. He had been touching black leather steering wheel cover and seat arm rest in his car (not new). Heat index at time in area was >100 degree's. There were scattered red mascules to posterior arm (upper/lower). This pruritic non-scaly red macular rash (heat rash) progressed over next 12-24 hours to include bilateral feet, groin, and posterior knees. He described any facial or chest lesions, oral lesions, or systemic symptoms such as headaches, fevers, nausea, vomiting, diarrhea, joint pain, or respiratory distress. he denied any target lesions. He did admit to mild myalgia which resolved within 24-48 hours. He did wear a new uniforma from new cleaners but advised no skin reactions with other uniforms cleaned at the same facility at same time. He denied any new detergents, deordorants, food groups, colognes, etc. He denied any recent illness but does work at a hospital. He self treated this "rash" with topical BENADRYL and colloidal oatmeal bath with relief of symptoms after 3 days. He admitted to difficulty sleeping x 3 days due to itchy feet. On day 13 96/28/2010) he was referred to Vaccine Healthcare Center by Immunization department of VAERS submission and concerns about possible diagnossi of Erythema Multiforme. Symptoms: Rash, oth nonspecific skin eruption(782.1).
Age: 20.0
Sex: M
Vaccine: HEP, MNQ, TDAP
Symptoms: Fatigue, Headache, Nausea, Pain
Clinical narrative: He went TCH on 6/22-(hospital) Told him-he was building antibodies, sx's to be expected. The hosp. gave Doreacet. Helped his headache. 5 pm-Headache pounding, nauseau-tired, couples hrs. after ER visit Headache eased up-gone 2 days. Tired-no energy today still-6/29/10  and achy. No history of migraine HA. Nsgstudent- has returned to classes.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Urticaria
Clinical narrative: Onset redness of (L) arm at vac. site 1 day later. On set hives 1 1/2 week after vaccines.
Age: 4.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Body temperature increased, Oedema mouth, Oedema peripheral, Rash
Clinical narrative: 6-10-10 1030 a.m. got up with right arm swelling, at 1100 p.m. mouth swelling, rash on (R) am - given steroids, BENADRYL and EPI in ER, condition improved released to home 0615.
Age: 0.18
Sex: M
Vaccine: DTAPIPVHIB, PNC, RV1
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Localized swelling, redness at Rt deltoid site where Dtap #5 was given on 6/24/10, warm to touch and itchy, no pain. Pt was seen here 6/26/10 and advised cool compresses prn, BENADRYL prn and to call if worse or if fever developed.
Age: 15.0
Sex: F
Vaccine: HEPA, HPV4, TDAP
Symptoms: Syncope
Clinical narrative: Syncope episode lasting 10 sec.
Age: 1.32
Sex: M
Vaccine: DTAPIPVHIB, MMR, PNC13, VARCEL
Symptoms: Irritability, Rash
Clinical narrative: Rash covering torso and extremities. Irritable.
Age: 2.0
Sex: M
Vaccine: HIBV, MNQ
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Was taken to UCC then sent to ER left leg swelling sec from shots MENACTRA. At left thigh anterior lateral surface. There is minimal redness and swelling about 4x5cm and non-tender, no pus; no bleeding.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity, Post herpetic neuralgia
Clinical narrative: Pain in arm (deltoid) within hours of vaccine => neuralgia. Responded partially to 800 3xd acyclovir, no rash =>"Post herpetic neuralgia" character.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash vesicular
Clinical narrative: Pt developed chickenpox type rash on body and legs 1-2 wks after vaccine.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Drug exposure before pregnancy
Clinical narrative: Pt received GARDASIL #1->1/6/10 and received GARDASIL #2 5/11/10. Positive preg test 6/25/10.
Age: 17.0
Sex: M
Vaccine: HEPA, MNQ
Symptoms: Abdominal pain upper, Eye irritation, Headache, Injection site induration, Rash generalised
Clinical narrative: Shots given at about 2 PM, at 3:30 child c/o headache, stomach "hurt" and skin was hot to touch. Temp not taken, TYLENOL given. Also c/o "eyes burning." The next AM, he had a generalized "goose bumps" type rash, that itched. There was a quarter sized induration on her (R) arm - site of MCV4 vaccine. Rash on leg relieved somewhat by BENADRYL, but rash lasted 2 days.
Age: 17.0
Sex: M
Vaccine: HEPA, MNQ
Symptoms: Rash pruritic, Skin warm, Tuberculin test
Clinical narrative: Shots given at about 2 PM, at 3:30 child c/o headache, stomach "hurt" and skin was hot to touch. Temp not taken, TYLENOL given. Also c/o "eyes burning." The next AM, he had a generalized "goose bumps" type rash, that itched. There was a quarter sized induration on her (R) arm - site of MCV4 vaccine. Rash on leg relieved somewhat by BENADRYL, but rash lasted 2 days.
Age: 1.01
Sex: M
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Eye swelling, Swelling face, Urticaria
Clinical narrative: Facial swelling (R) eye swollen shut. Hives on body. Given BENADRYL, Prednisone in ER & given Rx for BENADRYL and Prednisone.
Age: 15.0
Sex: F
Vaccine: HEPA
Symptoms: Dizziness, Immediate post-injection reaction, Syncope
Clinical narrative: Pt received Hep A injection and felt dizzy right after injection. Then had an episode of syncope. Only lasted 5-7 seconds. Pt was tx with fluids and calories (pt was fasting). Vitals were stable.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Body temperature increased, Chills
Clinical narrative: Chills, temperature of 104 degrees F.
Age: 3.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Rash erythematous
Clinical narrative: Red, swollen, hot to the touch area localized around the injection site.  Spread over the next few days.  Swelling decreased, but darkened, red rash remains at one week post administration.
Age: 7.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: 2 inch diameter swollen and tender area around injections site.
Age: 37.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Petechiae, Pruritus
Clinical narrative: Developed red raised rash on both upper extremities. (fine petechial rash) The injection site became red and swollen and painful.
Age: 37.0
Sex: F
Vaccine: DTAP
Symptoms: Rash, Rash erythematous
Clinical narrative: Developed red raised rash on both upper extremities. (fine petechial rash) The injection site became red and swollen and painful.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site discolouration, Injection site erythema, Injection site swelling
Clinical narrative: Increasing swelling and redness with purple discoloration in the center (approximately 3 inches in diameter) to R thigh at site of DTaP vaccine.  Area of redness and swelling approximately 1-2 inches in diameter located on L upper arm at site of Varicella vaccine.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Swollen, redness to injection site, pain soreness.
Age: 12.0
Sex: F
Vaccine: HPV4, MEN, TDAP, VARCEL
Symptoms: Infection, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Pain, swelling, and redness of tricep area of left arm since vaccine given on 6/7/10 pt treated for infection 6/9/10 infection improved 6/11/10 following first Gardasil vaccination. Mother certain the vaccine was Gardasil. The staff who administered the vaccines noted that varicella was given in the tricep area and the Gardisil was administered in the deltoid of left arm.
Age: 4.0
Sex: M
Vaccine: PNC13
Symptoms: Dermatitis bullous, Erythema, Oedema peripheral, Pruritus
Clinical narrative: 1) Per mother, night received Prevnar-13 vaccine left thigh, child itchy same night.  2) Following day became, red and swollen. 3) Father had administered cream for left thigh.  3) SEEN IN OFFICE 6-14-2010 - showed multiple bullous lesions left thigh, neg sloughing, PICTURE taken in chart.
Age: 65.0
Sex: F
Vaccine: FLUX
Symptoms: Headache
Clinical narrative: Severe headache.
Age: 1.29
Sex: M
Vaccine: MMR
Symptoms: Erythema, Pyrexia, Rash
Clinical narrative: High fever of 104.1. After fever, red rash all over his face.
Age: 15.0
Sex: F
Vaccine: HEP
Symptoms: Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 15-year-old female subject who was vaccinated with Hepatitis B (manufacturer unspecified). On an unspecified date the subject received unspecified dose of Hepatitis B (unknown). At an unspecified time after vaccination with Hepatitis B, the subject experienced uveitis. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis B vaccine between 1982 and 2009. It appeared that all subjects recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 36.0
Sex: M
Vaccine: HEP
Symptoms: Ankylosing spondylitis, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 36-year-old male subject who was vaccinated with hepatitis B vaccine recombinant (Hepatitis B vaccine, manufacturer unspecified). On an unspecified date the subject received unspecified dose of Hepatitis B vaccine (unknown). At an unspecified time after vaccination with Hepatitis B vaccine, the subject experienced uveitis and ankylosing spondylitis. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 1.0
Sex: M
Vaccine: HEP
Symptoms: Arthritis, Injection site reaction, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 1-year-old male subject who was vaccinated with HEPATITIS B vaccine (manufacturer unspecified). On an unspecified date the subject received unspecified dose of HEPATITIS B vaccine (unknown). At an unspecified time after vaccination with HEPATITIS B vaccine, the subject experienced uveitis, arthritis and injection site reaction. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after Hepatitis B vaccine 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of Hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic Hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the Hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 26.0
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Nausea, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 26-year-old female subject who was vaccinated with hepatitis B vaccine recombinant (Hepatitis B vaccine, manufacturer unspecified). On an unspecified date the subject received 2nd dose of Hepatitis B vaccine (unknown). One day after vaccination with Hepatitis B vaccine, the subject experienced uveitis, dizziness and nausea. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Headache, Lymphadenopathy, Meningitis, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 28-year-old female subject who was vaccinated with Hepatitis B vaccine, (manufacturer unspecified). Previous and/or concurrent vaccination included Salmonella typhi Vi capsular polysaccharide vaccine; manufacturer unspecified given on an unspecified date. On an unspecified date the subject received 1st dose of Hepatitis B vaccine (unknown). One day after vaccination with Hepatitis B vaccine, the subject experienced uveitis, headache, lymphadenopathy and meningitis. This case was assessed as medically serious by GSK. This is one of 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 22.0
Sex: F
Vaccine: HEP
Symptoms: Blindness, Uveitis
Clinical narrative: This case was reported in a literature article and described the occurrence of uveitis in a 22-year-old female subject who was vaccinated with hepatitis B vaccine recombinant (Hepatitis B vaccine, manufacturer unspecified). On an unspecified date the subject received 1st dose of Hepatitis B vaccine (unknown). Three days after vaccination with Hepatitis B vaccine, the subject experienced uveitis and vision loss. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Age: 23.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Patient experienced localized redness that spread distally from the injection site on patients right deltoid.  Patient also experienced minor localized pain at injection site.
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Oedema peripheral
Clinical narrative: Redness and swelling at injection site; swelling of right arm, hand including fingers, induration and tenderness at injection site, started when patient woke up this AM; given instructions to ice, Atarax PRN itching and Amoxicillin if redness starts spreading and/or fever develops.
Age: 0.24
Sex: M
Vaccine: 6VAX-F, PPV, RVX
Symptoms: Crying, Diarrhoea, Induration, Injection site pain, Insomnia
Clinical narrative: Patient became sore and sleepy within 20 minutes of vaccinations (DTP, Hep B, IPV, HIB, PCV, & Rotavirus). For the next two weeks his legs were rigid and hard as rocks near the vaccination sites, he had diarrhea, cried almost constantly, stopped sleeping through the night, ran a low fever, his legs hurt him even with a soft touch he would scream.  This lasted for two weeks and slowly went away.